Piper Sandler raised the firm’s price target on Abacus Life (ABL) to $13 from $12 and keeps an Overweight rating on the shares following quarterly earnings. Given the strength through the first three quarters of the year and the outlook, the firm is increasing its adjusted EBITDA estimate, Piper told investors.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter